Partner Content Partner Content The ryze-elluminate integration to maximise automation in cl... The ryze-elluminate integration
Partner Content Partner Content The prevailing desire uniting patients, HCPs, and payers: a ... Milo Elmir on trends shaping stakeholder's behavior
Partner Content Partner Content Formedix launches Community Forum to support the clinical tr... Formedix launches the ryze Community Forum
Events Partner Content SMi’s 6th Annual Highly Potent Active Pharmaceutical Ingredi... SMi’s 6th Annual Highly Potent Active Pharmaceutical Ingredients 9th and 10th May 2022 London, UK www.highlypotentapi.com/pharmaphorum
Partner Content Partner Content 6 critical success factors of a successful rapid first comme... Annemarie Armstrong shares key factors for rapid launch
Partner Content Partner Content Formedix Partnered with CDISC to Give Free Access to CDASH-C... Free access to CDASH-Compliant eCRFs
News TransThera's resistant biliary cancer drug cleared in China TransThera's Yochanra has been cleared in China as the world's first drug that can overcome resistance to FGFR inhibitors in cholangiocarcinoma.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
